Skip to main content

AVITA Medical, Inc.

RCEL
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001762303

In the last 90 days, AVITA Medical, Inc. insiders filed 1 open-market purchase and 0 sales; 73 institutions reported holding it in 13F filings for Q2 2026, worth $20.4M in total; no superinvestor holds it.

Other share classesAVHHL

Q2 2023 vs. Q1 2023

How the institutions holding AVITA Medical, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of RCEL: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders7280+8
Shares5.89M7.61M+1.72M (+29.1%)
Value$82.5M$129.5M+$47.0M (+56.9%)

New holders (25)

Institutions that held AVITA Medical, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to RCEL in Q2 2023
InstitutionSharesValue% of portfolio
Russell Investments Group, Ltd.215,518$3.67M0.01%
Calamos Advisors LLC85,786$1.46M0.01%
Nuveen Asset Management, LLC84,998$1.45M0.00%
Soleus Capital Management, L.P.75,000$1.28M0.14%
Advisory Research Inc47,094$801.1K0.10%
STRS Ohio36,000$612.0K0.00%
Segantii Capital Management Ltd30,000$510.3K0.03%
Rhumbline Advisers27,029$459.8K0.00%
MetLife Investment Management13,645$232.1K0.00%
American Century Companies Inc12,620$214.7K0.00%
Mirae Asset Global Investments Co., Ltd.12,416$211.2K0.00%
American International Group, Inc.12,100$205.8K0.00%
Deutsche Bank AG11,349$193.0K0.00%
New York State Common Retirement Fund10,200$173.5K0.00%
Voya Investment Management LLC10,104$171.9K0.00%
California State Teachers Retirement System8,362$142.2K0.00%
Barclays PLC5,008$85.2K0.00%
Amalgamated Bank3,811$65.0K0.00%
PEAK6 Investments LLC3,770$64.1K0.01%
Legal & General Group Plc3,044$51.8K0.00%
Ameritas Investment Partners, Inc.2,076$35.3K0.00%
Dorsey Wright & Associates1,467$25.0K0.01%
Metropolitan Life Insurance Co1,414$24.1K0.00%
Tower Research Capital LLC (TRC)624$10.6K0.00%
IFP Advisors, Inc183$5.59K0.00%

Sold out (17)

Institutions that held AVITA Medical, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.